December 14, 2022
How to Apply
Submit an application online and provide two letters of support. For more detailed instructions, see award description. Please see the separate application link for 2nd year submission instructions. Application Deadline: December 14, 2022 at 5:00pm EST
To promote early career research development of academic pediatric endocrinologists.
Qualifications of Candidate
Senior fellows or early stage faculty members who are PES members in good standing are eligible to apply for the Clinical Scholar Award. Applicants must provide institutional documentation of junior faculty status at the planned time of the award with the additional stipulations as noted below. US citizenship or green card status is NOT required. Those with career plans in North America are favored. Further, the PES is committed to a culture of equity, diversity and inclusion, and aims for a distribution of awardees that reflects and celebrates the diversity of people and cultures of our membership.
A candidate may apply for support if he or she:
- Is in the final year of training as an endocrinology fellow or is within the first 3 years of a full-time junior faculty position in Pediatric Endocrinology.
- Has either an MD or DO degree.
- Has completed a minimum of 2 years of pediatric endocrinology fellowship training.
- Has a faculty rank that is no higher than Assistant Professor.
- Does not have K12, K23, K08 or other K level funding and is not a PI on an R21, R01, or NSF award at the time of grant award period.
Should the candidate have other forms of extramural research support, they must submit their hypotheses and budget to identify potential overlaps in funding.
Note that multiple applications from one institution may be submitted, but only one application will be funded from a single institution.
Awardees will be expected to present their research findings at an oral plenary session at the national PES meeting at the conclusion of the granting period. PES will also request that awardees indicate acknowledgement of funding from the PES and provide copies of all manuscripts generated from work supported by the PES grant as well as information about awardees’ future academic appointments and subsequent grant awards for 5 years following completion of the PES award.
Two letters of support are required and should be submitted with the application. One must be from the Division Chief (Sponsor) and the other from the Research Mentor (individual supervising the research project). The latter should be an established investigator with a record of current extramural support as evidenced on their NIH Biosketch. If the Division Chief and Research Mentor are the same person, a letter from the Department Chair is required. Additionally, applicants must establish an appropriate mentoring committee and provide the names and qualifications of these committee members.
Amount of Award
The award is up to $50,000 for one year. The exact amount of funding for each review cycle will be determined by the Awards Committee depending on the amount of available funds at the time of review of the application. Funding for a second year will be based on submission of a progress report and the competitive renewal of the proposal.
Please see the separate application link for 2nd year submission instructions.
Awardees are requested to notify the committee of any delays in the progress of their proposal. For funds that are not used during the term of the grant award, a one-time request for a no-cost extension (NCE) can be made to the Awards Committee and Board of Directors of PES, and, if approved, a 1-year NCE will be granted. Support from the Clinical Scholar award is only for research-related expenses and research career development, including technical support. The Sponsor must verify salary support for the Scholar. The funds shall not be used for the salary of the awardee, and institutions may not use more than 5% of the grant award for indirect or overhead expenses. Concomitant funding for the project from other grants is permitted. However, if a candidate holds or is applying for any other grant that proposes studies related to those in the CSA, PES requests that a copy of the specific aims, hypotheses, and budget of the other grant(s) be included in the CSA application so that reviewers can assess the degree of potential overlap.
General Instructions for Application
Applications will need to be submitted on-line through the PES website. An applicant must be a member of PES (dues paid for this current year) to be able to access the application. Applicants will then be directed to register. This will allow initiation of the application process and enable returning to finish different sections at a later time using the registration log-in.
Parts 3 and 4 under the Applicant Section should include a description of the Candidate’s Background, Goals and Objectives, the Career Development Plan, a Research Plan, Bibliography, and a detailed Budget and Budget Justification.
- The Candidate’s Background, Goals and Objectives (up to 1 page) must describe the candidate’s commitment to an academic career, discuss prior training and research experience and how this relates to the goals and objectives of the candidate, provide evidence of the candidate’s potential to develop into an independent investigator, and describe the short-term and long-term goals and objectives of the candidate
- The Candidate’s Career Development Plan (up to 1 page) should include a description of the skills and competencies that are to be achieved, the development/training/mentored activities through which the competencies will be achieved, and a timeline for execution of these competencies. This plan should be designed to move the candidate from the mentored phase to the independent phase of their research career over about 5 years
- The Research Plan (up to 5 pages not including the Bibliography) must have intrinsic research importance and serve as a suitable vehicle for learning the theories, methodologies, and conceptualizations necessary to become an independent investigator. The Research Plan should be formatted as follows: Specific Aims, Significance, Innovation and Approach (to include preliminary data, study design, methods, analytical plan with a power statement, and pitfalls and alternative strategies).
The application should be in Arial 11 font with at least 0.5 inch margins.
An application not compliant with these guidelines or received after the due date will be returned to the applicant and not reviewed.
If the application includes the use of human subjects or animals, please provide documentation at the time of application submission that the protocol has been submitted for Human Subjects or IACUC approval. Human Subjects or IACUC approval must be provided before an award can be made to the institution.
General Scoring of Applications
Applications will be reviewed by the PES Awards Committee, as well as by expert external reviewers. Reviewers will use the NIH grant application 9-point scale scoring system for the Overall Impact Score and Individual Scores for five core criteria: Significance, Investigator, Innovation, Approach, and Environment.
Deadline: December 14, 2022, 5:00 PM, EST
2022 - 2023
- Mansa Krishnamurthy, MD, MSc - Using Patient Derived Induced Pluripotent Stem Cells To Model Novel Genetic Causes of Congenital Hyperinsulinism
- Marie-Eve Robinson, M.D., C.M., MSc(epi) -Shifting the focus for children with skeletal dysplasias from a conventional medical approach to a biophysical model centered on health-related quality of life
- Jia Zhu, MD - Dissecting PCOS Physiology by Defining Phenotypes Associated with PCOS Genetic Risk Factors in Men and Children
- Brittany Bruggerman, MD - Natural History and Mechanisms of Exocrine Pancreatic Dysfunction in Pre-Type 1 Diabetes
2021 - 2022
- Brittany Bruggeman - Natural History and Mechanisms of Exocrine Pancreatic Dysfunction in Pre-Type 1 Diabetes
- Alaina Widmar - Time Limited Eating in Adolescents with Type 2 Diabetes (Time LEAD)
- Jia Zhu - Dissecting PCOS Physiology by Defining Phenotypes Associated with PCOS Genetic Risk Factors in Men and Children
- Janet Lee, MD - Bone density, structure, and estimated strength in gender diverse youth initiating gender-affirming therapy in early puberty
- Elizabeth Rosenfeld, MD- Leveraging Novel Neuroimaging Techniques to Comprehensively Characterize Neurodevelopmental Differences in Congenital Hyperinsulinism
- Jordan Sherwood, MD- Feasibility of Automated Glycemic Control of Cystic Fibrosis-Related Diabetes with the Bionic Pancreas in a Pediatric Cohort
2019 - 2020
- Daniel Zeve – Reprogramming Gastrointestinal Stem Cells into Endocrine Cells
- Despoina Manousaki - Identifying clinically-relevant circulating protein biomarkers for type 1 diabetes
2018 - 2019
- Miranda Broadney, MD, MPH - Break It Up: A study evaluating the effects of interrupting daily sedentary behavior in youth on glucose tolerance and lipid metabolism
- Amanda Ackerman, MD, PhD - Identifying Targets to Enhance β Cell Response in Diabetes Using Single-Cell Functional Genomics
- Shylaja Srinivasan, MD - Understanding the Genetic Determinants of Weight Loss in Response to Therapeutic Interventions for Type 2 Diabetes in Adults and Children
- Stephanie Roberts - Transgenic Expression of Mkrn3 in the Arcuate Nucleus of the Hypothalamus: Impact on the Neuroendocrine Control of Puberty and Reproduction
2017 - 2018
- Charumathi Baskaran - Role of gonadal hormones in regulation of anxiety and depression in athletes
- Shanlee Davis - Energy metabolism in boys with Klinefelter Syndrome
- Christine Ferrara - Genetic variants of lipid metabolism and the effect on beta-cell function in type 1 diabetes
2016 - 2017
- Shylaja Srinivasan, MD - Genetics of type 2 diabetes and related therapeutic strategies in youth
- Youn Hee Jee, MD - The role of PSD-93 in the initiation of puberty and in the etiology of pubertal delay
- Stephanie Roberts, MD - Transgenic expression of Mkrn3 in the arcuate nucleus of the hypothalamus: impact on the neuroendocrine control of puberty and reproduction
2015 - 2016
- Jeffrey Roizen, MD, PhD - CYP2R1, the Vitamin D 25-hydroxylase, a critical mechanistic link between disease and serum 25(OH)D
- Emily Sims, MD - β cell Derived miR-21 as an Intrinsic Protective Response and Biomarker in Type 1 Diabetes
- Diana Stanescu, MD - The maturation of pancreatic endocrine cells in human development
- Stephanie Sisley, MD - Mechanisms of CNS Vitamin D in weight regulation
2014 - 2015
- Shana McCormack, MD - Translational investigation of abnormal fat metabolism in mitochondrial disease
- Jennifer Todd, MD - Genetic association studies of diabetic nephropathy
2013 - 2015
- Janet Crane, MD - Temporal-spatial regulation of differentiation of mesenchymal stem cells by Insulin-like growth factor Type 1 and relationship to peak bone mass acquisition
- Lily Chao, MD - Nur77 – a novel regulator of muscle growth
- Andrew Dauber M.D. - Rare genetic variants as novel causes of short stature
- Natalie Shaw, M.D. - The interaction between sleep and reproductive hormone secretion during puberty
- Yee-Ming Chan, M.D., PhD - Using kisspeptin to interrogate the human GnRH network
- Mark DeBoer, M.D. - Improving endocrine-related outcomes in pre-pubertal colitis
- Elvira Isganaitis, M.D. - Obesity and diabetes risk following prenatal undernutrition: identifying molecular mechanisms and targeted therapies
- Nancie J. MacIver, M.D. - Leptin as a regulator of T cell metabolism and function
- Jennifer Yee, M.D. - Effect of SCD1 Inhibition on adipocyte differentiation in newborn rats programmed to develop adult obesity
- Clement Cheung, M.D., Ph.D. - A novel transcriptional factor in VMH development and physiology
- Scott Blackman, M.D. - Genetic modifiers of diabetes in cystic fibrosis
- Maureen Su, M.D. - The Role of central tolerance in autoimmune endocrinopathies
- Sara DiVall, M.D. - Growth factor regulation of the GnRH neuron
- Brian Feldman, M.D. - Role of the glucocorticoid receptor in adipogenesis and implications for diabetes and metabolism
- Amy Fleischman, M.D. - Mitochondrial function and insulin resistance in obese and lean children
- Dennis Chia, M.D.
- Michael Haller, M.D.
- Sudha Biddinger, M.D.
- Sheela Natash Magge, M.D.
- Kuk-Wha Lee, M.D., Ph.D.
- Bradley S. Miller, M.D., Ph.D.
- Jennifer L. Miller, M.D.
- Radhika Muzumdar, M.D.
- David T. Breault, M.D., Ph.D.
- Robert J. Ferry, Jr., M.D.
- Andrea M. Haqq, M.D.
- Jake A. Kushner, M.D.
- Kathleen Bethin, M.D.
- David Geller, M.D., Ph.D.
- Andrea Kelly, M.D.
- Anna Spagnoli, M.D.
- Atul Butte, M.D.
- Rubina Heptulla, M.D.
- Stephen Huang, M.D.
- Daniel Marks, M.D., Ph.D.
- Adda Grimberg, M.D.
- Mark R. Palmert, M.D., Ph.D.
- Pamela M. Thomas, M.D.
- Ruben Diaz, M.D., Ph.D.
- Michael P. Wajnrajch, M.D., Ph.D.
- Jon M. Nakamoto, M.D., Ph.D.
- Cheri L. Deal, M.D., Ph.D.
- Patricia Y. Fechner, M.D.
- Stephen E. Gitelman, M.D.
- Charmian A. Quigley, M.D.
- Paul M. Martha, Jr., M.D.
- Scott A. Rivkees, M.D.
- Nancy J. Charest, M.D.
- Samuel J. Casella, M.D.